Pentostatin in steroid refractory acute graft versus host disease.

被引：0
|
作者：
Jacobsohn, D [1 ]
Margolis, J [1 ]
Anders, V [1 ]
Phelps, M [1 ]
Grever, M [1 ]
Vogelsang, G [1 ]
机构：
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Bone Marrow Transplant Program, Baltimore, MD 21218 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1628
引用
收藏
页码：420A / 420A
页数：1
相关论文
共 50 条
  • [31] Limited benefit of pentostatin salvage therapy for steroid-refractory grade III-IV acute graft-versus-host disease
    Alam, Naheed
    Atenafu, Eshetu G.
    Tse, Garwin
    Viswabandya, Auro
    Gupta, Vikas
    Kim, Dennis
    Lipton, Jeffrey H.
    Messner, Hans A.
    Kuruvilla, John
    CLINICAL TRANSPLANTATION, 2013, 27 (06) : 930 - 937
  • [32] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    Hoda, D.
    Pidala, J.
    Salgado-Vila, N.
    Kim, J.
    Perkins, J.
    Bookout, R.
    Field, T.
    Perez, L.
    Ayala, E.
    Ochoa-Bayona, J. L.
    Raychaudhuri, J.
    Alsina, M.
    Greene, J.
    Janssen, W.
    Fernandez, H. F.
    Anasetti, C.
    Kharfan-Dabaja, M. A.
    BONE MARROW TRANSPLANTATION, 2010, 45 (08) : 1347 - 1351
  • [33] Steroid-Refractory Acute Graft-versus-Host Disease: Is There an Effective Therapy?
    Antin, Joseph H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : 146 - 148
  • [34] Infliximab for treatment of steroid refractory acute and chronic graft-versus-host disease
    Trenschel, R
    Trampenau, C
    Ditschkowski, M
    Elmaagacli, A
    Ottinger, H
    Steckel, N
    Biersack, H
    Peceny, R
    Beelen, D
    BONE MARROW TRANSPLANTATION, 2003, 31 : S128 - S129
  • [35] Infliximab for Managing Steroid-Refractory Acute Graft-versus-Host Disease
    Pidala, Joseph
    Kim, Jongphil
    Field, Teresa
    McBride, Ali
    Kharfan-Dabaja, Mohamed
    Perkins, Janelle
    Fernandez, Hugo
    Perez, Lia
    Ayala, Ernesto
    Anasetti, Claudio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (09) : 1116 - 1121
  • [36] Treatment and Nursing for Steroid-Refractory Acute Graft-Versus-Host Disease
    Cazeau, Naomi
    Rodriguez, Stephany L.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (04) : 397 - 403
  • [37] Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease
    Gomez-Almaguer, David
    Ruiz-Arguelles, Guillenmo J.
    Tarin-Arzaga, Luz del Carmen
    Gonzalez-Llano, Oscar
    Gutierrez-Aguirre, Homero
    Cantu-Rodriguez, Olga
    Jaime-Perez, Jose
    Carrasco-Yalan, Antonio
    Giralt, Sergio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (01) : 10 - 15
  • [38] Mesenchymal stem cell therapy for steroid refractory acute graft versus host disease
    Anak, Sema
    Yaman, Yontem
    Ozdilli, Kursat
    Bilgen, Hulya
    Saribeyoglu, Ebru Tugrul
    Hazar, Volkan
    Ayman, Fatma Nur
    Elli, Murat
    BONE MARROW TRANSPLANTATION, 2019, 54 : 320 - 321
  • [39] Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab
    Willenbacher, W
    Basara, N
    Blau, IW
    Fauser, AA
    Kiehl, MG
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 820 - 823
  • [40] Beyond ruxolitinib in steroid-refractory acute graft-versus-host disease
    Lee, Catherine J.
    Pusic, Iskra
    Savani, Bipin N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 306 - 307
12345